Mara Venier Undergoes Eye Surgery for Maculopathy
Table of Contents
Italian television personality Mara Venier recently underwent surgery on her right eye to address ongoing issues with maculopathy. The surgery took place at the end of December 2025, following a previous operation in November of the same year, and is part of a series of treatments she has received for the condition.
Understanding Maculopathy
Maculopathy is a general term for a range of conditions affecting the macula, the central part of the retina responsible for sharp, central vision. It can cause blurred or distorted vision, and in severe cases, vision loss. Several types of maculopathy exist, including age-related macular degeneration (AMD), which is the leading cause of vision loss in people over 60. Other causes can include genetics,vascular issues,and inflammation.
Mara Venier’s History with Maculopathy
Venier publicly discussed her condition on her program Domenica In in November 2025, explaining she experienced a sudden hemorrhage in the retina of her right eye.she has undergone multiple surgeries – five in the past year – to manage the condition and preserve her vision. She shared updates on her condition via Instagram,posting a video from her hospital bed expressing hope for a better new year. She also publicly thanked her doctor, Andrea Cusumano, for his care.
Recovery and Outlook
Following the surgery, Venier is currently in convalescence. While the recovery process can vary depending on the type of maculopathy and the specific treatment received,it often involves rest and avoiding strenuous activity. The goal of treatment is to slow the progression of the disease and preserve remaining vision. Regular monitoring by an ophthalmologist is crucial for managing maculopathy and adapting to any changes in vision.
Primary Topic: Health/Celebrity Health News
Primary Keyword: Mara Venier Maculopathy
Secondary Keywords: Maculopathy, Eye Surgery, Italian Television, Domenica In, Andrea Cusumano, Retina Hemorrhage, Vision Loss, Eye Health, Convalescence.